We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$730M
AUM Growth
+$169M
Cap. Flow
+$111M
Cap. Flow %
15.2%
Top 10 Hldgs %
18.73%
Holding
130
New
27
Increased
88
Reduced
13
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 19.94%
2 Technology 17.32%
3 Financials 16.14%
4 Healthcare 11.97%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
B
26
DELISTED
Barnes Group Inc.
B
$9.51M 1.3%
200,545
+27,416
+16% +$1.19M
MD icon
27
Pediatrix Medical
MD
$2.2B
$9.39M 1.29%
140,840
+21,167
+18% +$1.38M
AER icon
28
AerCap
AER
$23.4B
$9.16M 1.25%
220,103
+33,155
+18% +$1.39M
CHE icon
29
Chemed
CHE
$7.16B
$8.67M 1.19%
54,070
+8,646
+19% +$1.27M
CMCO icon
30
Columbus McKinnon
CMCO
$422M
$8.33M 1.14%
308,197
+3,574
+1% +$80.3K
NOVT icon
31
Novanta
NOVT
$4.91B
$8.11M 1.11%
386,349
-10,538
-3% -$201K
INWK
32
DELISTED
InnerWorkings, Inc.
INWK
$8.07M 1.1%
819,079
-25,095
-3% -$232K
OPB
33
DELISTED
Opus Bank Common Stock
OPB
$7.92M 1.08%
263,511
+97,544
+59% +$2.6M
REI icon
34
Ring Energy
REI
$307M
$7.79M 1.07%
599,356
-13,403
-2% -$155K
PACW
35
DELISTED
PacWest Bancorp
PACW
$7.65M 1.05%
140,539
+20,789
+17% +$1M
OA
36
DELISTED
Orbital ATK, Inc.
OA
$7.61M 1.04%
86,723
+23,372
+37% +$1.9M
TCF
37
DELISTED
TCF Financial Corporation Common Stock
TCF
$7.43M 1.02%
137,235
+23,420
+21% +$1.14M
MRCY icon
38
Mercury Systems
MRCY
$5.41B
$7.43M 1.02%
245,965
-15,154
-6% -$430K
AEL
39
DELISTED
American Equity Investment Life Holding Company
AEL
$7.35M 1.01%
326,221
+51,269
+19% +$1.02M
BBT
40
Beacon Financial Corp
BBT
$2.5B
$7.12M 0.97%
193,183
+26,409
+16% +$849K
PBH icon
41
Prestige Consumer Healthcare
PBH
$2.47B
$6.91M 0.95%
132,669
+19,544
+17% +$943K
SP
42
DELISTED
SP Plus Corporation
SP
$6.8M 0.93%
241,671
-4,238
-2% -$112K
CCRN
43
DELISTED
Cross Country Healthcare
CCRN
$6.76M 0.93%
433,131
+42,023
+11% +$575K
UMPQ
44
DELISTED
Umpqua Holdings Corp
UMPQ
$6.76M 0.93%
359,829
+60,594
+20% +$1.03M
EPAY
45
DELISTED
Bottomline Technologies Inc
EPAY
$6.72M 0.92%
268,679
+27,491
+11% +$653K
GWB
46
DELISTED
Great Western Bancorp, Inc.
GWB
$6.7M 0.92%
153,705
+16,345
+12% +$611K
FFBC icon
47
First Financial Bancorp
FFBC
$3.55B
$6.57M 0.9%
231,037
+42,479
+23% +$1.05M
AZPN
48
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$6.55M 0.9%
119,826
+19,615
+20% +$1.07M
WWE
49
DELISTED
World Wrestling Entertainment
WWE
$6.41M 0.88%
348,514
+49,334
+16% +$934K
WAB icon
50
Wabtec
WAB
$49.3B
$6.32M 0.87%
76,151
+5,548
+8% +$457K

Similar funds

Aristotle Capital Boston's Q4 2016 Portfolio in Review

As of Q4 2016, Aristotle Capital Boston held 130 positions worth $730M, up 30% from $561M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $111M of net new capital in Q4 2016, opening 27 new positions and adding to 88 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Wabash National, an estimated $1.35M trimmed.

  • Aristotle Capital Boston's largest Q4 2016 buy was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
  • Aristotle Capital Boston added most to iShares Russell 2000 ETF in Q4 2016, an estimated $9.41M increase.
  • Aristotle Capital Boston's biggest Q4 2016 reduction was Wabash National, cutting an estimated $1.35M.
  • Aristotle Capital Boston fully exited Amsurg Corp in Q4 2016, selling an estimated $10.2M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $730M portfolio in Q4 2016.
  • Aristotle Capital Boston opened 27 new positions and closed 2 in Q4 2016.
  • Aristotle Capital Boston's portfolio value rose 30% quarter-over-quarter to $730M.

Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.